Inventor · disambiguated record
Jonathan D. Benson
Also filed as: BENSON JONATHAN · BENSON JONATHAN D
14 granted patents·3 pending applications·265 citations·filing 2011–2024
92Inventor score
Top patents by PatentIndex Score
17 records- 0198US8501930B2Peptide-based in vivo siRNA delivery systemROZEMA DAVID B·Filed 2011·Granted Aug 6, 2013·180 cites·18 claims
- 0295US8802773B2In vivo polynucleotide delivery conjugates having enzyme sensitive linkagesROZEMA DAVID B·Filed 2013·Granted Aug 12, 2014·12 cites·22 claims
- 0395US8426554B2In vivo polynucleotide delivery conjugates having enzyme sensitive linkagesROZEMA DAVID B·Filed 2011·Granted Apr 23, 2013·47 cites·14 claims
- 0492US10246709B2Targeting ligands for therapeutic compoundsARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Apr 2, 2019·10 cites·27 claims
- 0587US2025243485A1Targeting Ligands For Therapeutic CompoundsARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0686US10927373B2Compositions and methods for inhibiting gene expression of Hif2alphaARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Feb 23, 2021·2 cites·20 claims
- 0786US9976141B2Compositions and methods for inhibiting gene expression of Hif2alphaARROWHEAD MADISON INC·Filed 2016·Granted May 22, 2018·5 cites·32 claims
- 0883US9107957B2Peptide-based in vivo siRNA delivery systemARROWHEAD MADISON INC·Filed 2013·Granted Aug 18, 2015·5 cites·14 claims
- 0982US11597701B2Integrin ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Mar 7, 2023·2 cites·24 claims
- 1076US12116573B2Targeting ligands for therapeutic compoundsARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Oct 15, 2024·0 cites·3 claims
- 1176US9803201B2Disulfide-containing alkyne linking agentsARROWHEAD MADISON INC·Filed 2016·Granted Oct 31, 2017·1 cites·14 claims
- 1274US11840688B2Compositions and methods for inhibiting gene expression of Hif2alphaARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Dec 12, 2023·0 cites·20 claims
- 1369US9481661B2Disubstituted maleic anhydrides with altered kinetics of ring closureBLOKHIN ANDREI V·Filed 2012·Granted Nov 1, 2016·1 cites·4 claims
- 1467US2024076270A1Integrin ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1562US10047361B2Disulfide-containing alkyne linking agentsARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Aug 14, 2018·0 cites·12 claims
- 1662US2019211333A1Targeting Ligands For Therapeutic CompoundsARROWHEAD PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1758US10059681B2Disubstituted maleic anhydrides with altered kinetics of ring closureARROWHEAD MADISON INC·Filed 2016·Granted Aug 28, 2018·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →